Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3

被引：33
|
作者：
Reiter, LA [1 ]
Mitchell, PG [1 ]
Martinelli, GJ [1 ]
Lopresti-Morrow, LL [1 ]
Yocum, SA [1 ]
Eskra, JD [1 ]
机构：
[1] Pfizer Inc, Global Res & Dev, Groton Labs, Groton, CT 06340 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 14期
关键词：
D O I：
10.1016/S0960-894X(03)00413-X
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Phosphinic acid-based inhibitors of MMP-13 have been investigated with the aim of identifying potent inhibitors with high selectivity versus MMP-1. Independent variation of the substituents on a P-1' phenethyl group and a P-2 benzyl group improved potencies in both cases around 3-fold over the unsubstituted parent. Combining improved P-1' and P-2 groups into a single molecule gave an inhibitor with a 4.5 nM IC50 against MMP-13 and which is 270-fold selective over MMP-1. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2331 / 2336
页数：6
相关论文
共 50 条
  • [1] α-amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1
    Becker, DP
    Barta, TE
    Bedell, L
    DeCrescenzo, G
    Freskos, J
    Getman, DP
    Hockerman, SL
    Li, M
    Mehta, P
    Mischke, B
    Munie, GE
    Swearingen, C
    Villamil, CL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2719 - 2722
  • [2] LEPTIN ENHANCES MMP-1, MMP-3, AND MMP-13 PRODUCTION IN HUMAN OSTEOARTHRITIC CARTILAGE
    Koskinen, A.
    Vuolteenaho, K.
    Kukkonen, M.
    Nieminen, R.
    Moilanen, T.
    Moilanen, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (05) : 406 - 406
  • [3] Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients
    Koskinen, A.
    Vuolteenaho, K.
    Nieminen, R.
    Moilanen, T.
    Moilanen, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 57 - 64
  • [4] Enhanced production of MMP-1, MMP-3, MMP-13, and RANTES by interaction of chondrocytes with autologous T cells
    Hiroshi Nakamura
    Michiaki Tanaka
    Kayo Masuko-Hongo
    Kazuo Yudoh
    Tomohiro Kato
    Moroe Beppu
    Kusuki Nishioka
    Rheumatology International, 2006, 26 : 984 - 990
  • [5] Enhanced production of MMP-1, MMP-3, MMP-13, and RANTES by interaction of chondrocytes with autologous T cells
    Nakamura, Hiroshi
    Tanaka, Michiaki
    Masuko-Hongo, Kayo
    Yudoh, Kazuo
    Kato, Tomohiro
    Beppu, Moroe
    Nishioka, Kusuki
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (11) : 984 - 990
  • [6] Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk
    Zhai, Yun
    Qiu, Wei
    Dong, Xiao-Jia
    Zhang, Xiu-Mei
    Xie, Wei-Min
    Zhang, Hong-Xing
    Yuan, Xiao-Yan
    Zhou, Gang-Qiao
    He, Fu-Chu
    GUT, 2007, 56 (03) : 445 - 447
  • [7] Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket
    Reiter, LA
    Rizzi, JP
    Pandit, J
    Lasut, MJ
    McGahee, SM
    Parikh, VD
    Blake, JF
    Danley, DE
    Laird, ER
    Lopez-Anaya, A
    Lopresti-Morrow, LL
    Mansour, MN
    Martinelli, GJ
    Mitchell, PG
    Owens, BS
    Pauly, TA
    Reeves, LM
    Schulte, GK
    Yocum, SA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) : 127 - 132
  • [8] Design of selective, nonpeptidic MMP-3, MMP-8 and MMP-13 inhibitors based on 3-D-QSAR methods
    Amin, EA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U589 - U590
  • [9] MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
    Tolboom, T. C. A.
    Pieterman, E.
    van der Laan, W. H.
    Huidekoper, A. L.
    Nelissen, R. G. H. H.
    Breedveld, F. C.
    Huizinga, T. W. J.
    ARTHRITIS RESEARCH & THERAPY, 2001, 3 (Suppl 2)
  • [10] MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
    TCA Tolboom
    E Pieterman
    WH van der Laan
    AL Huidekoper
    RGHH Nelissen
    FC Breedveld
    TWJ Huizinga
    Arthritis Research & Therapy, 3
12345